4D Molecular Therapeutics Inc
FDMT
NASDAQ
Biotechnology
$12.19
USD
+0.54 (+4.64%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $609.02M
Volume 773.7K
Price Target
$36.00 – $36.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $36.00 and a min estimate of $36.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$36.00
+$6.5 vs prior
Implied Upside
+195.3%
+53.3% vs prior
Analyst Covering
1
-3 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
20%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Matthew Caufield | HC Wainwright & Co. | Buy | Reiterated | 3 weeks ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
SGMT
Sagimet Biosciences Inc
$10.55
▲ +13.7%
EIKN
Eikon Therapeutics Inc
$11.05
▲ +7.0%
MDXG
MiMedx Group Inc
$4.27
▲ +1.7%
ALLO
Allogene Therapeutics Inc
$2.05
▲ +3.5%
CBIO
Crescent Biopharma Inc
$17.14
▲ +3.1%
ALT
Altimmune Inc
$2.94
▲ +2.1%
TECX
Tectonic Therapeutic Inc
$34.91
▲ +2.7%
ASMB
Assembly Biosciences Inc
$32.95
▲ +10.0%
NVCT
Nuvectis Pharma Inc
$18.96
▼ -1.4%